ACR 2022 Tweet by Mike Putman

Nice #SLE validation study. This kind of work is (1) time intensive and (2) thankless!

It's not flashy but it winds up being the backbone/foundation for many subsequent studies

Need more in other diseases, including sarcoidosis and myositis! @DidemSayginMD

#ACR22 @RheumNow